Document Detail


Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma.
MedLine Citation:
PMID:  20153664     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVES: The effect of induction chemotherapy (IC) on lung function and exercise capacity in patients with malignant pleural mesothelioma (MPM) has not been largely examined. The aim of this study was to evaluate the changes in pulmonary function and oxygen consumption following IC in patients with MPM.
METHODS: Between 2004 and 2009, 36 consecutive patients (mean age 62.1 + or - 1.5 years, M/F = 25/11) were prospectively investigated. Data concerning medical history, histology, staging and response to chemotherapy were collected. All patients underwent pulmonary function test before (in the absence of pleural effusion) and after chemotherapy (platinum-based agent plus pemetrexed); 23 out of 36 patients also performed a cardiopulmonary incremental exercise test.
RESULTS: An epithelioid histotype was documented in 88.8% of patients. A partial response to chemotherapy was observed in 44.5% of cases and 36.1% of patients experienced grade 2-3 toxicity. A significant improvement in forced expiratory volume in 1s (FEV(1)) (0.13 + or - 0.30 l; P = 0.01), in VO(2) peak (1.76 + or - 2.91 ml kg(-1) min(-1); P = 0.005), in PaO(2) at rest (4.76 + or - 9.84 mmHg; P = 0.03) and in PaO(2) at peak exercise (6.26 + or - 12.72 mmHg; P = 0.04) was detected. The diffusion capacity of the lung for carbon monoxide (DLCO) also increased (1.25 + or - 4.68 ml min(-1) mmHg(-1)), although not significantly (P = 0.20). The stratified analysis based on the response to IC showed a significant improvement in FEV(1), forced vital capacity (FVC) and vital capacity (VC) (both absolute and percentage of predicted values) only in patients with a partial response.
CONCLUSIONS: An improvement in lung function and exercise capacity was seen after IC in patients with MPM. These data suggest that IC does not compromise cardiopulmonary performance in this subset of patients.
Authors:
Giuseppe Marulli; Federico Rea; Samuele Nicotra; Adolfo Gino Favaretto; Egle Perissinotto; Maddalena Chizzolini; Andrea Vianello; Fausto Braccioni
Related Documents :
3082064 - Pathological changes of the lungs after prolonged inhalation of high concentrations of ...
3571074 - Effect of volume history on distribution of inspired gas in asthmatics.
1302754 - Pulmonary alveolar microlithiasis--report of three cases with pulmonary function and ex...
21419804 - Cognitive and locomotor/exploratory behavior after chronic exercise in the olfactory bu...
2113754 - Synchronization of locomotion and respiration in trotting ponies.
6290144 - Sympathoadrenal reactivity in exercise-induced asthma.
Publication Detail:
Type:  Journal Article     Date:  2010-02-12
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  37     ISSN:  1873-734X     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1464-9     Citation Subset:  IM    
Copyright Information:
Copyright 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Affiliation:
Cardiothoracic and Vascular Sciences Department, Thoracic Surgery Division, University of Padua, Padua, Italy. beppemarulli@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-inflammatory haemoglobin scavenging monocytes are induced following coronary artery bypass surg...
Next Document:  Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.